Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05344196 · ClinicalTrials.gov registry record · NA
Emotional Awareness and Expression Therapy for Prediabetes
A NA study, sponsored by Wayne State University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05344196: Completed NA study, sponsored by Wayne State University.
NCT05344196 is a NA study that has completed, run by Wayne State University. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05344196, a NA study, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This feasibility study seeks to develop and pilot test Emotional Awareness and Expression Therapy as a possible treatment for people with prediabetes.
Primary Outcome
Hemoglobin A1c from venous blood
Interventions
- BEHAVIORAL Modified EAET for prediabetes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2022-12-15 |
| Phase | NA |
What the finished NCT05344196 record still lists
NCT05344196 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Modified EAET for prediabetes is the first listed.
NCT05344196 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05344196 about?
NCT05344196 is a clinical study titled "Emotional Awareness and Expression Therapy for Prediabetes". This feasibility study seeks to develop and pilot test Emotional Awareness and Expression Therapy as a possible treatment for people with prediabetes.
What is the current status of trial NCT05344196?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2022-03-01. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT05344196?
The interventions under investigation include: Modified EAET for prediabetes (BEHAVIORAL).
Who is sponsoring clinical trial NCT05344196?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05344196's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI